课题基金 / 基金详情

项目摘要

项目成果

Gavin James Braithwaite的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Retinal disorders are a common cause of debilitating vision loss. For many of these conditions, including retinal detachments and macular holes, the only treatment is surgery. The first step of all such surgeries is vitrectomy, the process of removing the vitreous gel through tiny ports in the front of the eye. Each year, 1.1 million vitrectomies are performed globally with 300,000 performed in the US alone, and in the majority of these cases a retinal tamponade is required to be left in the eye to maintain pressure on the retina and aid healing. The global retinal tamponade market was recently valued at USD $64.5 million in 2013 and is predicted to reach USD $77.5 million by 2020. The current state of the art uses either an expansile gas, or a silicone oil to exert pressure on the retina during healing (tamponade). However, neither method is ideal and therefore to address these deficiencies, this proposal develops a novel hydrogel that uses two common synthetic biomedical polymers, namely a modified poly(vinyl alcohol) and poly(ethylene glycol) in a form that creates a unique hydrogel system that is very low viscosity in liquid form but then gels through crosslink formation in the eye. This formulation allows for injection through small surgical ports followed by in vivo expansion resulting in 360-degree retinal tamponade. This unique formulation will eliminate the need for post-operative patient positioning. Additionally, this hydrogel degrades over the period of 3-5 weeks providing a temporary tamponade force before degrading to small molecules that are readily cleared from the eye, thus removing the need for subsequent surgeries to remove the tamponade agent. The resulting device will be more patient friendly with almost no refractive issues and the ability for the patient to be fully mobile. Patient compliance will therefore be improved. In addition, it will also act as a tamponade only for the surgically relevant period of time before clearing naturally through a degradation process reducing costs and improving outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Degradable hydrogel for retinal tamponade (phase 2)
  • 批准号:
    10219260
  • 项目类别:
  • 资助金额:
    $29.64万
  • 财政年份:
    2020
  • 负责人:
    Gavin James Braithwaite
  • 依托单位:
Degradable hydrogel for retinal tamponade (phase 2)
  • 批准号:
    9908974
  • 项目类别:
  • 资助金额:
    $29.61万
  • 财政年份:
    2020
  • 负责人:
    Gavin James Braithwaite
  • 依托单位:
Injectable, biocompatible poly (vinyl alcohol) hydrogels for tissue bulking
  • 批准号:
    7747226
  • 项目类别:
  • 资助金额:
    $9.83万
  • 财政年份:
    2009
  • 负责人:
    Gavin James Braithwaite
  • 依托单位:
An injectable biocompatible hydrogel nucleus pulposus replacement
  • 批准号:
    7744555
  • 项目类别:
  • 资助金额:
    $7.67万
  • 财政年份:
    2009
  • 负责人:
    Gavin James Braithwaite
  • 依托单位:
国内基金
海外基金
湍流和化学交互作用对H2-Air-H2O微混燃烧中NO生成的影响研究
  • 批准号:
    51976048
  • 项目类别:
    面上项目
  • 资助金额:
    61.0万元
  • 批准年份:
    2019
  • 负责人:
    邱朋华
  • 依托单位: